OCV Partners overview
OCV Partners contact information
Offices
4700 Wilshire Blvd, Los Angeles, 90010, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Richard Ressler | Job titleCo-Founder and Chairman | LocationLos Angeles, United States | Email  ----------- |
| Mr. Hemi Zucker | Job titleManaging Partner | LocationLos Angeles, United States | Email ----------- |
| Mr. Chris Bostick | Job titlePartner | LocationLos Angeles, United States | Email --------- |
| Mr. Andy Liu | Job titlePartner | LocationLos Angeles, United States | Email --------- |
OCV Partners funds managed
Closed funds: 1
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size -------- | Close dateSep 2017 | Strategy ----- | |
Stories that mention OCV Partners
Praxis Precision Medicines starts trading on NASDAQ
Cambridge, Massachusetts-based Praxis Precision Medicines, a developer of treatments for central nervous system disorders, has raised about $190 million for its IPO after pricing 10 million shares at $19 per share.
Finch Therapeutics rallies $90m Series D
Somerville, Massachusetts-based Finch Therapeutics Group Inc, a clinical-stage microbiome drug development company, has secured $90 million in Series D financing.
Praxis Precision Medicines attracts $110m
Cambridge, Massachusetts-based Praxis Precision Medicines, a biopharmaceutical company, has raised $110 million in Series C1 financing.
ByHeart nets $70m Series A
New York City-based ByHeart, a maker of infant and baby nutrition products, has raised $70 million in Series A funding.
Finch Therapeutics lands $53 mln Series C
Somerville, Massachusetts-based Finch Therapeutics Group Inc, a microbiome therapeutics company, has raised $53 million in Series C financing. The investors included OCV Partners, Susquehanna International Group, Symbiosis LLC, the Trans-Pacific Technology Fund, Avenir Growth Capital, Morgan Noble, Shumway Capital and Willett Advisors.
Figure8 procures $40 mln Series A
Figure8, "an experience-first development company," has secured $40 million in Series A funding. The investors were Elizabeth Street Ventures, Maywic Select Investment and OCV Partners.